Over the past decade, South America has faced severe arboviral outbreaks, including the Zika virus in 2015–16 and recurring cases of chikungunya and dengue, particularly impacting Brazil. Adding to this trend, the region is now experiencing an unprecedented resurgence of the Oropouche virus, posing new challenges for public health.

By August 1, 2024, there were 8,078 confirmed cases of Oropouche fever reported across Bolivia, Brazil, Colombia, and Peru, with the virus establishing an endemic presence in Cuba. Additionally, a few cases have been identified in Italy and Spain among travelers returning from Cuba, highlighting the potential for global spread. This outbreak reflects a notable shift in the virus’s transmission pattern, as Oropouche—first detected in Trinidad and Tobago in 1955—was primarily confined to forested regions and spread by midges and mosquitoes. However, current trends indicate that the virus can now also spread in densely populated urban areas, amplifying its public health risks.

The rapid spread of Oropouche in urban areas mirrors transmission patterns seen in other arboviruses, raising concerns about control and prevention. As an arboviral disease, Oropouche virus typically causes symptoms like fever, headache, muscle pain, and, in severe cases, neurological complications, impacting healthcare resources in affected areas. The expansion of its reach in cities intensifies these demands.

This report calls for enhanced surveillance, cross-border cooperation, and research into effective vector control methods to curb its spread. Public health agencies are advised to monitor travel-related cases and prepare for potential outbreaks beyond the Americas. Research on vaccines and treatment is crucial as urban transmission complicates containment strategies. Addressing this arboviral threat requires coordinated responses and resources to mitigate its health and economic impacts on the region and beyond.1

Read more here.

References

  1. Diseases, N. L. I. (2024). Oropouche fever, the mysterious threat. The Lancet Infectious Diseases, 24(9), 935. https://doi.org/10.1016/s1473-3099(24)00516-4

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred